Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Thiohydantoin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for thiohydantoin drugs avoiding toxic reagents. Improved yield and safety for commercial scale-up of androgen receptor antagonists.
Patent CN119546579A enables high-yield synthesis of prostate cancer drug intermediates, ensuring supply chain stability and significant cost efficiency.